Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15829378rdf:typepubmed:Citationlld:pubmed
pubmed-article:15829378lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C0149925lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C0253023lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C1539477lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C1533716lld:lifeskim
pubmed-article:15829378lifeskim:mentionsumls-concept:C1999230lld:lifeskim
pubmed-article:15829378pubmed:issue2lld:pubmed
pubmed-article:15829378pubmed:dateCreated2005-4-14lld:pubmed
pubmed-article:15829378pubmed:abstractTextThe Fas/Fas ligand (FasL) system is a major regulator of apoptosis. Chemotherapeutic drugs have been shown to induce Fas expression on the surface of lung cancer cells, and cancer cell apoptosis. However, this mechanism is not considered to be associated with Fas expressed on lung cancer cells. Soluble Fas and FasL concentrations are reportedly elevated in the peripheral blood of patients with lung cancer, but the roles of circulating soluble Fas and FasL in that disease have not been clarified.lld:pubmed
pubmed-article:15829378pubmed:languageenglld:pubmed
pubmed-article:15829378pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15829378pubmed:citationSubsetIMlld:pubmed
pubmed-article:15829378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15829378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15829378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15829378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15829378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15829378pubmed:statusMEDLINElld:pubmed
pubmed-article:15829378pubmed:issn0361-090Xlld:pubmed
pubmed-article:15829378pubmed:authorpubmed-author:YamakiKenichi...lld:pubmed
pubmed-article:15829378pubmed:authorpubmed-author:KumeHiroakiHlld:pubmed
pubmed-article:15829378pubmed:authorpubmed-author:ItoYasushiYlld:pubmed
pubmed-article:15829378pubmed:authorpubmed-author:KondoMasashiMlld:pubmed
pubmed-article:15829378pubmed:authorpubmed-author:SuzukiRyujiro...lld:pubmed
pubmed-article:15829378pubmed:authorpubmed-author:ShimizuMakoto...lld:pubmed
pubmed-article:15829378pubmed:issnTypePrintlld:pubmed
pubmed-article:15829378pubmed:volume29lld:pubmed
pubmed-article:15829378pubmed:ownerNLMlld:pubmed
pubmed-article:15829378pubmed:authorsCompleteYlld:pubmed
pubmed-article:15829378pubmed:pagination175-80lld:pubmed
pubmed-article:15829378pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:meshHeadingpubmed-meshheading:15829378...lld:pubmed
pubmed-article:15829378pubmed:year2005lld:pubmed
pubmed-article:15829378pubmed:articleTitleSoluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.lld:pubmed
pubmed-article:15829378pubmed:affiliationDepartment of Respiratory Medicine, Nagoya University School of Medicine 65, Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8560, Japan.lld:pubmed
pubmed-article:15829378pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15829378lld:pubmed